Arax Advisory Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
RI
FCM
Arax Advisory Partners's RARE Position: Q2 2026 in Review
Arax Advisory Partners increased its Ultragenyx Pharmaceutical (RARE) stake by 1,239% in Q2 2026, buying an estimated $463K and bringing the position to 20,160 shares worth $673K. The position accounts for ﹤0.01% of the portfolio, ranked #1441.
Arax Advisory Partners first reported a position in RARE in Q2 2024 and has held it in 9 quarters since. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.
- Arax Advisory Partners held 20,160 shares of Ultragenyx Pharmaceutical worth $673K as of Q2 2026.
- Arax Advisory Partners bought 18,654 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $463K.
- Ultragenyx Pharmaceutical made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1441 holding.
- Arax Advisory Partners first reported a position in Ultragenyx Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
- 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.